Skeletal Muscle Atrophy

Slide 1 · Skeletal muscle atrophy

Mechanisms, fiber patterns, and clinicopathologic interpretation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Classify the major causes of skeletal muscle atrophy.

Explain how denervation, disuse, and systemic catabolism reduce muscle mass.

Recognize grouped, perifascicular, and selective type II fiber atrophy.

Use motor-unit remodeling to interpret muscle biopsy patterns.

Slide 3 · Atrophy is a change in size and sometimes cell number

Reduced trophic or metabolic input

Myofiber shrinkage

Reduced muscle mass and function

Early loss of cell volume predominates.

Prolonged atrophy may involve loss of myofibers.

Slide 4 · Skeletal muscle atrophy is a shared endpoint

Loss of innervation, disuse, cachexia, aging, and primary myopathies can all reduce muscle mass.

Atrophy is a morphologic response—not a single etiologic diagnosis.

The distribution of small fibers can suggest the mechanism.

Slide 5 · A myofiber is a large multinucleated cell

Fascicle (conceptual cross-section)

Myoblast fusion forms myotubes that mature into myofibers.

Multiple myofibers are organized within muscle fascicles.

Fiber size reflects structural proteins and organelle content.

Schematic — not a histologic specimen

Slide 6 · Satellite cells contribute to regeneration

Myofiber injury

Satellite-cell activation

Fusion to damaged fiber

Structural restoration

Regeneration is possible after transient injury.

Chronic damage may exceed repair capacity.

Slide 7 · Type I and type II fibers perform different tasks

Property

Type I

Type II

Dominant activity

Sustained force

Fast movement

Typical exercise

Aerobic

Anaerobic

Power

Lower

Higher

Fatigue resistance

Higher

Lower

Slide 8 · Fiber types differ in substrate and mitochondria

Property

Type I

Type II

Oxidative capacity

High

Lower

Glycolytic capacity

Lower

High

Mitochondrial density

High

Lower

Lipid content

Higher

Lower

Glycogen content

Lower

Higher

Slide 9 · Histochemical reaction depends on fiber type

Stain / enzyme reaction

Type I

Type II

NADH–TR

Darker

Lighter

ATPase, pH 4.3

Darker

Lighter

ATPase, pH 9.4

Lighter

Darker

Slide 10 · Normal muscle has a checkerboard admixture

Type I

Type II

Type I and type II fibers are intermixed rather than segregated into large blocks.

Motor units of different fiber types are intermingled.

The checkerboard appearance is a useful baseline for recognizing remodeling.

Schematic — not a histologic image

Slide 11 · Five major contexts lead to muscle atrophy

Denervation

Reduced use

Cachexia / malnutrition

Old age

Primary myopathy

Each context can produce reduced muscle fiber size.

Morphologic pattern and clinical context help separate causes.

Slide 12 · Neuropathic and myopathic injury begin at different sites

Neurogenic process

Myopathic process

Motor neuron or axon is injured.

Myofibers lose innervation and trophic input.

Grouped atrophy and fiber type grouping may emerge.

Muscle fiber is injured directly.

Necrosis and regeneration may occur.

Chronic injury may lead to fibrosis and fatty replacement.

Slide 13 · Disuse produces early myofiber shrinkage

Cast immobilization / bed rest

Decreased workload

Reduced myofiber size

Rapid onset after immobilization.

Initial size reduction can be reversible.

Slide 14 · Duration matters in disuse atrophy

Earlier disuse

Prolonged disuse

Reduced fiber size is prominent.

Recovery may follow return to activity.

Fiber number may also decrease.

Apoptosis contributes to loss of fibers.

Disuse osteoporosis can accompany muscle atrophy.

Slide 15 · Loss of innervation interrupts muscle maintenance

Motor nerve injury

Loss of trophic input

Myofiber shrinkage

Neurogenic atrophy

Denervated fibers may become flattened and angulated.

A distribution of affected fibers is more informative than size alone.

Slide 16 · Cachexia is a systemic cause of wasting

Malnutrition / inflammatory illness

Net catabolic state

Loss of skeletal muscle protein

Muscle wasting

Cancer and chronic inflammatory disease as contexts.

The clinical syndrome must not be inferred from a biopsy pattern alone.

Slide 17 · Old age and primary myopathies also cause atrophy

Aging-associated atrophy

Primary myopathic atrophy

Old age is among the causes listed by Robbins.

Age is clinical context, not a biopsy diagnosis by itself.

Fiber loss may coexist with direct myofiber injury.

Necrosis, regeneration, and chronic remodeling guide interpretation.

Slide 18 · Prolonged corticosteroid exposure can selectively affect type II fibers

Type I

Type II

Conceptual pattern: Type II fibers are preferentially smaller; Type I fibers are relatively spared.

This pattern is associated with prolonged corticosteroid therapy.

Disuse can produce a similar type II-predominant pattern.

Schematic — not a histologic image

Slide 19 · Distribution is the first morphologic question

Observed pattern

Association

Grouped atrophic fibers

Neurogenic disease

Perifascicular atrophy

Dermatomyositis

Type II atrophy with type I sparing

Disuse or prolonged corticosteroids

Slide 20 · Cellular atrophy reflects loss of protein balance

Protein synthesis decreases

Protein degradation increases

Lower trophic input reduces translation.

Fewer structural proteins are replaced.

Both changes contribute to cell shrinkage.

Ubiquitin–proteasome activity rises.

Autophagy may also increase.

The result is net loss of cellular material.

Slide 21 · Reduced trophic signaling lowers protein synthesis

Lower growth / trophic input

Reduced nutrient uptake / translation

Reduced structural protein synthesis

Reduced trophic signals to diminished synthesis.

Reduced synthesis contributes to a smaller myofiber.

Slide 22 · Ubiquitin–proteasome signaling drives proteolysis

Disuse or nutrient deficiency

Ubiquitin ligase activation

Protein ubiquitination

Proteasomal degradation

The pathway is implicated in several catabolic states, including cancer cachexia.

Diagram presents the source-level mechanism—not a disease-specific molecular assay.

Slide 23 · Autophagy may accompany tissue atrophy

Atrophic stress

Autophagic vacuoles increase

Cellular constituents are degraded

Autophagy contributes to turnover of cellular components.

Residual bodies can persist when material resists complete digestion.

Slide 24 · Atrophic myofibers have fewer intracellular components

Normal myofiber

Atrophic myofiber

Relatively abundant myofilaments.

Mitochondria and rough ER support normal metabolism.

Fewer myofilaments and mitochondria.

Reduced rough ER and overall cell volume.

Lower metabolic requirements.

Slide 25 · Early adaptation trades capacity for survival

Lower nutrient / trophic supply

Lower cellular demand

Reduced function but cell survival

Cell death is initially limited in many forms of atrophy.

Severe or persistent adverse conditions can exceed adaptive capacity.

Slide 26 · Reversibility depends on the context and duration

Potentially reversible

More persistent damage

Early disuse with myofiber shrinkage.

Return of activity restores useful stimulation.

Long-standing disuse may reduce fiber number.

Chronic disease can be accompanied by loss of fibers.

Slide 27 · Atrophy should be separated from myofiber necrosis

Atrophy

Necrosis / regeneration

Predominant reduction in cell size.

Protein turnover can be altered without acute cell death.

Segmental myofiber injury and myophagocytosis.

Satellite-cell fusion and sarcomere replacement.

Slide 28 · Small fibers can form distinctive tissue patterns

Grouped

Perifascicular

Type II-selective

Type I

Type II

Schematic: Fiber positions and sizes are illustrative, not a histologic specimen.

Analyze position, clustering, and fiber type—not merely average fiber diameter. No single pattern should replace clinical and ancillary interpretation.

Slide 29 · A motor unit links one motor neuron to multiple fibers

Motor

Neuron

Axon

One axon supplies multiple muscle fibers

Schematic

A motor unit consists of one motor neuron, its axon, and the myofibers it innervates.

All fibers within a single motor unit share a functional fiber type.

Slide 30 · The innervating neuron determines muscle fiber type

Motor

Neuron

Axon

All fibers of this unit acquire the type specified by its motor neuron

Schematic

Innervation influences whether an individual fiber behaves as type I or type II.

Loss and restoration of innervation can change fiber-type identity.

Slide 31 · Normal motor units interdigitate

Type I

Type II

Schematic mixed fiber types at baseline.

Fibers belonging to different motor units are interspersed.

Consequently, intact muscle does not show large homogeneous fiber-type territories.

Schematic — not a histologic image

Slide 32 · Denervated fibers become small and angulated

Schematic loss of size and rounded profile in a subset of fibers.

Denervation-related atrophic fibers may be flattened and angulated.

Shape reflects the neurogenic response.

Schematic — not a histologic image

Slide 33 · Grouped atrophy suggests disruption of innervation

Clustered small fibers in a conceptual muscle cross-section.

Several adjacent small fibers together form a grouped atrophy pattern.

Robbins treats this as a characteristic neurogenic clue.

Schematic — not a histologic image

Slide 34 · Collateral reinnervation enlarges surviving motor units

Motor

Neuron

Axon

Expanded motor unit

After collateral reinnervation

Schematic

Residual axons may reinnervate fibers abandoned by damaged axons.

One surviving motor neuron can come to supply more myofibers.

Slide 35 · Reinnervation may change the fiber type

Initial denervation

Contact by a new motor axon

Fiber-type change

Fiber-type grouping

The remodeled fibers now share the type specified by their new axon.

This explains large adjacent same-type fiber territories.

Slide 36 · Fiber type grouping records motor-unit remodeling

Type I

Type II

Clustered same-type fibers after collateral reinnervation.

Adjacent fibers share the same fiber type.

This is distinct from a mere cluster of small atrophic fibers.

Schematic — not a histologic image

Slide 37 · Grouped atrophy may recur after reinnervation

Axonal loss

Collateral reinnervation

Enlarged motor unit

Later loss of its axon

Grouped atrophy

Large remodeled motor units are vulnerable when their remaining axon degenerates.

The sequence explains why grouping and grouped atrophy can coexist.

Slide 38 · Neurogenic atrophy appears in several clinical settings

Clinical context

Level of motor-unit injury

Amyotrophic lateral sclerosis

Motor neuron degeneration

Radiculopathy

Motor root injury

Peripheral neuropathy

Peripheral nerve / axonal injury

Slide 39 · Spinal muscular atrophy illustrates a motor-neuron cause

SMN1 loss of function

Motor neuron loss

Failure of normal muscle innervation

Widespread neurogenic atrophy

Spinal muscular atrophy as autosomal recessive.

This is an etiologic example, not a diagnosis from atrophy alone.

Slide 40 · Severe infantile SMA shows striking fiber-size disparity

Source-described pattern: Many markedly small rounded fibers with scattered preserved or enlarged fibers.

The larger fibers retain innervation and may hypertrophy.

This differs in appearance from simple uniform disuse shrinkage.

Schematic — not a histologic image

Slide 41 · Perifascicular atrophy localizes to fascicle edges

Small fibers are preferentially located along the fascicular perimeter.

The defining feature is spatial—not simply a high proportion of small fibers.

This as a classic dermatomyositis-associated pattern.

Schematic — not a histologic image

Slide 42 · Dermatomyositis provides the key clinical association

Dermatomyositis is a systemic autoimmune disease involving muscle and characteristic skin manifestations.

The muscle weakness is typically proximal.

Perifascicular atrophy supports the morphologic diagnosis when present.

It is not present in every case.

Slide 43 · Perifascicular atrophy is not universally present

Finding present

Finding absent

Edge-predominant small fibers provide a useful clue.

Interpret together with other pathologic and clinical findings.

Absence does not exclude dermatomyositis.

Avoid treating a single morphologic sign as an absolute criterion.

Slide 44 · Grouped and perifascicular atrophy answer different questions

Grouped atrophy

Perifascicular atrophy

A cluster of neighboring small fibers.

Supports a neurogenic mechanism.

May follow loss of an enlarged motor unit.

Small fibers lie preferentially at fascicle margins.

Suggests dermatomyositis.

A spatial relation to the fascicle border.

Slide 45 · Fiber type must be identified for selective atrophy

Type I

Type II

Type II-selective shrinkage requires recognizing fiber type as well as size.

Type II fibers may be selectively reduced with type I sparing.

A routine size-only schematic cannot establish fiber type without appropriate typing.

Schematic — not a histologic image

Slide 46 · Disuse and corticosteroids overlap morphologically

Disuse

Prolonged corticosteroid therapy

Reduced workload is documented.

Type II fiber atrophy may occur.

Long-term exposure is the clinical context.

Type II fiber atrophy may occur.

Slide 47 · The morphology must be interpreted with history

Identify distribution

Assess fiber types

Review clinical context

Integrate likely mechanism

The same selective fiber-type pattern can have different associations.

This is a reasoning framework, not a stand-alone diagnostic algorithm.

Slide 48 · Myopathic injury has a different injury–repair sequence

Segmental fiber injury

Macrophage clearance

Satellite-cell fusion

New sarcomeres

Direct myofiber damage can coexist with atrophic fibers.

This pathway should not be mislabeled as simple disuse atrophy.

Slide 49 · Creatine kinase relates to myofiber damage

Direct injury

Atrophy alone

Segmental degeneration releases intracellular enzymes including CK.

CK helps document ongoing muscle damage.

Fiber shrinkage is not identical to necrosis.

Do not assume marked CK release from size loss alone.

Slide 50 · Chronic myopathy can reduce muscle substance

Repeated damage

Repair fails to keep pace

Myofiber dropout

Fibrosis / fatty replacement

These changes are described for chronic myopathic disease.

They point beyond isolated atrophy toward sustained tissue injury.

Slide 51 · Neurogenic and myopathic clues can be compared

Feature

Neurogenic pattern

Myopathic pattern

Initial insult

Loss of innervation

Direct myofiber injury

Characteristic structural clue

Angulated atrophic fibers / grouping

Segmental damage / regeneration

Chronic consequences

Motor-unit remodeling

Fibrosis and fatty replacement may occur

Slide 52 · Three diagnostic patterns: Compare distributions

Grouped

Perifascicular

Type II-selective

Type I

Type II

Schematic: Fiber positions and sizes are illustrative, not a histologic specimen.

Grouped = where small fibers cluster. Perifascicular = where they lie within a fascicle. Type II-selective = which fiber population is reduced.

Slide 53 · Morphology cannot replace clinical correlation

Pattern recognition narrows etiologic possibilities; It does not prove one cause.

Disuse and corticosteroid exposure share type II-predominant atrophy.

Neurogenic remodeling may show both fiber-type grouping and grouped atrophy.

Myopathic necrosis and regeneration point to additional disease mechanisms.

Slide 54 · Case 1 — clustered small fibers

A muscle biopsy contains small, angulated fibers in clusters. The history includes progressive weakness and peripheral nerve disease.

Which broad pathophysiologic category is favored by the biopsy pattern?

Slide 55 · Case 1 — interpret the clustering

Neurogenic atrophy is favored.

Grouped small/angulated fibers are a characteristic neurogenic response.

Investigate the site and cause of motor innervation loss.

The pattern does not identify one specific neurologic disorder.

Slide 56 · Case 2 — fiber-type selective shrinkage

A patient has reduced muscle activity after a prolonged period of immobilization. A fiber-typed biopsy shows smaller type II fibers with relative type I sparing.

Which association is supported, and which competing history should also be checked?

Slide 57 · Case 2 — integrate the exposure history

Disuse is supported; Prolonged corticosteroid exposure is a key alternative association.

Both settings can yield selective type II atrophy.

The fiber pattern cannot distinguish them without clinical data.

Avoid diagnosing a specific myopathy from this pattern alone.

Slide 58 · Case 3 — small fibers at fascicle margins

A patient with proximal weakness and characteristic inflammatory skin findings has a muscle biopsy with edge-predominant small myofibers.

Which distribution is present and which inflammatory myopathy does it suggest?

Slide 59 · Case 3 — connect location to disease

Perifascicular atrophy suggests dermatomyositis.

Preferential atrophy at fascicle borders defines the pattern.

The association is informative, but not universally present in the disease.

Correlate with the remaining clinical and pathologic evidence.

Slide 60 · Synthesis: Cause, morphologic pattern, interpretation

Context

Dominant teaching clue

Caution

Denervation

Grouped atrophy; Later type grouping

Not disease-specific

Dermatomyositis

Perifascicular atrophy

May be absent

Disuse / corticosteroids

Selective type II atrophy

Two overlapping associations

Chronic myopathy

Damage, regeneration, tissue replacement

Not simply atrophy

Slide 61 · Five principles to retain

Atrophy is a response shared by multiple diseases.

Distribution distinguishes grouped from perifascicular atrophy.

Fiber typing distinguishes type II-selective shrinkage.

Denervation and reinnervation remodel motor-unit territories.

Biopsy findings require clinical and etiologic integration.

Slide 62 · References and source scope

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 27, pp. 1116–1118.

Chapter 27: “Diseases of Skeletal Muscle,” “Skeletal Muscle Atrophy,” and adjacent neurogenic/myopathic sections.

Chapter 27, Table 27.2: Muscle Fiber Types; Figures 27.7–27.9 interpreted from text/captions only.

Chapter 2, pp. 54–55: Atrophy and Mechanisms of Atrophy.